Literature DB >> 16308188

Coated-platelets retain amyloid precursor protein on their surface.

Calin I Prodan1, Robert Szasz, Andrea S Vincent, Elliott D Ross, George L Dale.   

Abstract

Coated-Platelets are a subset of platelets produced by dual-agonist activation with collagen plus thrombin and are characterized by strong retention of several procoagulant, alpha-granule proteins on the cell surface. In this report we demonstrate that coated-platelets also retain full-length amyloid precursor protein (APP) on their surface in contrast to the cleavage of APP in platelets activated with a single agonist. In addition, western blot analysis indicated that APP is derivatized during coated-platelet synthesis. We subsequently measured coated-platelet production in patients with Alzheimer's disease (AD). Twenty-two AD patients showed a wide distribution of coated-platelet values; however the least impaired AD patients produced coated-platelets at a level significantly above that of aged controls (41.0 +/- 9.9 vs. 28.7 +/- 11.4%; mean +/- 1SD; p = 0.017). These findings suggest that coated-platelets may be a model of aberrant APP processing in early AD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16308188     DOI: 10.1080/09537100500181913

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  10 in total

1.  Coated-platelets correlate with disease progression in Alzheimer disease.

Authors:  Calin I Prodan; E D Ross; A S Vincent; G L Dale
Journal:  J Neurol       Date:  2007-03-22       Impact factor: 4.849

Review 2.  Platelet biomarkers in Alzheimer's disease.

Authors:  Leda L Talib; Helena Pg Joaquim; Orestes V Forlenza
Journal:  World J Psychiatry       Date:  2012-12-22

3.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

4.  Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction.

Authors:  Calin I Prodan; Julie A Stoner; Linda D Cowan; George L Dale
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

5.  Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.

Authors:  A J Tafur; G Dale; M Cherry; J D Wren; A S Mansfield; P Comp; S Rathbun; J A Stoner
Journal:  Thromb Res       Date:  2015-10-08       Impact factor: 3.944

6.  Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease.

Authors:  C I Prodan; E D Ross; J A Stoner; L D Cowan; A S Vincent; G L Dale
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

Review 7.  Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Authors:  Ilaria Canobbio; Aisha Alsheikh Abubaker; Caterina Visconte; Mauro Torti; Giordano Pula
Journal:  Front Cell Neurosci       Date:  2015-03-03       Impact factor: 5.505

8.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

9.  Blood platelets in the progression of Alzheimer's disease.

Authors:  Nina S Gowert; Lili Donner; Madhumita Chatterjee; Yvonne S Eisele; Seyda T Towhid; Patrick Münzer; Britta Walker; Isabella Ogorek; Oliver Borst; Maria Grandoch; Martin Schaller; Jens W Fischer; Meinrad Gawaz; Sascha Weggen; Florian Lang; Mathias Jucker; Margitta Elvers
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 10.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.